#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=Mary C. Tanner
1-1	0-4	Mary	person[1]	new[1]	coref	2-1[0_1]
1-2	5-7	C.	person[1]	new[1]	_	_
1-3	8-14	Tanner	person[1]	new[1]	_	_

#Text=Mary
2-1	15-19	Mary	person	giv	coref	4-1

#Text=Catherine
3-1	20-29	Catherine	person	new	_	_

#Text=Tanner
4-1	30-36	Tanner	person	giv	coref	9-5

#Text=is an investment banker , with more than 25 years of experience on Wall Street .
5-1	37-39	is	_	_	_	_
5-2	40-42	an	person[6]	new[6]	ana	6-1[0_6]
5-3	43-53	investment	abstract|person[6]	new|new[6]	_	_
5-4	54-60	banker	person[6]	new[6]	_	_
5-5	61-62	,	person[6]	new[6]	_	_
5-6	63-67	with	person[6]	new[6]	_	_
5-7	68-72	more	person[6]|time[7]	new[6]|new[7]	_	_
5-8	73-77	than	person[6]|time[7]	new[6]|new[7]	_	_
5-9	78-80	25	person[6]|time[7]	new[6]|new[7]	_	_
5-10	81-86	years	person[6]|time[7]	new[6]|new[7]	_	_
5-11	87-89	of	person[6]|time[7]	new[6]|new[7]	_	_
5-12	90-100	experience	person[6]|time[7]|abstract[8]	new[6]|new[7]|new[8]	_	_
5-13	101-103	on	person[6]|time[7]|abstract[8]	new[6]|new[7]|new[8]	_	_
5-14	104-108	Wall	person[6]|time[7]|abstract[8]|organization[9]	new[6]|new[7]|new[8]|new[9]	_	_
5-15	109-115	Street	person[6]|time[7]|abstract[8]|organization[9]	new[6]|new[7]|new[8]|new[9]	_	_
5-16	116-117	.	_	_	_	_

#Text=She specializes in the areas of biotechnology , pharmaceuticals , and health care services . [ 4 ] [ 5 ]
6-1	118-121	She	person	giv	ana	7-1
6-2	122-133	specializes	_	_	_	_
6-3	134-136	in	_	_	_	_
6-4	137-140	the	abstract[11]	new[11]	_	_
6-5	141-146	areas	abstract[11]	new[11]	_	_
6-6	147-149	of	abstract[11]	new[11]	_	_
6-7	150-163	biotechnology	abstract[11]|abstract	new[11]|new	_	_
6-8	164-165	,	abstract[11]	new[11]	_	_
6-9	166-181	pharmaceuticals	abstract[11]|substance	new[11]|new	coref	7-4[21_0]
6-10	182-183	,	abstract[11]	new[11]	_	_
6-11	184-187	and	abstract[11]	new[11]	_	_
6-12	188-194	health	abstract[11]|abstract|abstract[16]	new[11]|new|new[16]	_	_
6-13	195-199	care	abstract[11]|abstract|abstract[16]	new[11]|new|new[16]	_	_
6-14	200-208	services	abstract[11]|abstract[16]	new[11]|new[16]	_	_
6-15	209-210	.	_	_	_	_
6-16	211-212	[	_	_	_	_
6-17	213-214	4	abstract	new	coref	8-26
6-18	215-216	]	_	_	_	_
6-19	217-218	[	_	_	_	_
6-20	219-220	5	abstract	new	coref	8-29
6-21	221-222	]	_	_	_	_

#Text=Her expertise includes ethical pharmaceuticals and green technology . [ 1 ]
7-1	223-226	Her	person|abstract[20]	giv|new[20]	ana|ana	8-8|8-8
7-2	227-236	expertise	abstract[20]	new[20]	_	_
7-3	237-245	includes	_	_	_	_
7-4	246-253	ethical	substance[21]	giv[21]	coref	26-28[149_21]
7-5	254-269	pharmaceuticals	substance[21]	giv[21]	_	_
7-6	270-273	and	substance[21]	giv[21]	_	_
7-7	274-279	green	substance[21]|abstract[22]	giv[21]|new[22]	_	_
7-8	280-290	technology	substance[21]|abstract[22]	giv[21]|new[22]	_	_
7-9	291-292	.	_	_	_	_
7-10	293-294	[	_	_	_	_
7-11	295-296	1	abstract	new	coref	17-25
7-12	297-298	]	_	_	_	_

#Text=Fluent in both English and French , she specializes in cross-border transactions between large and small companies , corporate partnering and minority investments . [ 4 ] [ 5 ]
8-1	299-305	Fluent	_	_	_	_
8-2	306-308	in	_	_	_	_
8-3	309-313	both	abstract[24]	new[24]	_	_
8-4	314-321	English	abstract[24]	new[24]	_	_
8-5	322-325	and	_	_	_	_
8-6	326-332	French	abstract	new	_	_
8-7	333-334	,	_	_	_	_
8-8	335-338	she	person	giv	_	_
8-9	339-350	specializes	_	_	_	_
8-10	351-353	in	_	_	_	_
8-11	354-366	cross-border	abstract[27]	new[27]	_	_
8-12	367-379	transactions	abstract[27]	new[27]	_	_
8-13	380-387	between	abstract[27]	new[27]	_	_
8-14	388-393	large	abstract[27]|organization[28]	new[27]|new[28]	_	_
8-15	394-397	and	abstract[27]|organization[28]	new[27]|new[28]	_	_
8-16	398-403	small	abstract[27]|organization[28]	new[27]|new[28]	_	_
8-17	404-413	companies	abstract[27]|organization[28]	new[27]|new[28]	_	_
8-18	414-415	,	abstract[27]	new[27]	_	_
8-19	416-425	corporate	abstract[27]|abstract[29]	new[27]|new[29]	_	_
8-20	426-436	partnering	abstract[27]|abstract[29]	new[27]|new[29]	_	_
8-21	437-440	and	abstract[27]	new[27]	_	_
8-22	441-449	minority	abstract[27]|abstract|abstract[31]	new[27]|new|new[31]	_	_
8-23	450-461	investments	abstract[27]|abstract[31]	new[27]|new[31]	_	_
8-24	462-463	.	_	_	_	_
8-25	464-465	[	_	_	_	_
8-26	466-467	4	abstract	giv	coref	10-23
8-27	468-469	]	_	_	_	_
8-28	470-471	[	_	_	_	_
8-29	472-473	5	abstract	giv	coref	10-26
8-30	474-475	]	_	_	_	_

#Text=As of 2014 , Tanner was Senior Managing Director of EVOLUTION Life Science Partners ( ELSP ) , and a co-founder and chair of Life Science Partners LLP .
9-1	476-478	As	_	_	_	_
9-2	479-481	of	_	_	_	_
9-3	482-486	2014	time	new	coref	30-3
9-4	487-488	,	_	_	_	_
9-5	489-495	Tanner	person	giv	coref	9-7[37_0]
9-6	496-499	was	_	_	_	_
9-7	500-506	Senior	person[37]	giv[37]	coref	11-1[0_37]
9-8	507-515	Managing	organization|person[37]	new|giv[37]	coref	23-4
9-9	516-524	Director	person[37]	giv[37]	_	_
9-10	525-527	of	person[37]	giv[37]	_	_
9-11	528-537	EVOLUTION	person[37]|abstract|abstract[41]	giv[37]|new|new[41]	appos|coref|appos|coref	9-16[0_41]|30-9|9-16[0_41]|30-9
9-12	538-542	Life	person[37]|time|abstract[41]	giv[37]|new|new[41]	coref	25-30
9-13	543-550	Science	person[37]|organization|abstract[41]	giv[37]|new|new[41]	coref	9-26
9-14	551-559	Partners	person[37]|abstract[41]	giv[37]|new[41]	_	_
9-15	560-561	(	person[37]	giv[37]	_	_
9-16	562-566	ELSP	person[37]|abstract	giv[37]|giv	coref	9-27
9-17	567-568	)	person[37]	giv[37]	_	_
9-18	569-570	,	person[37]	giv[37]	_	_
9-19	571-574	and	person[37]	giv[37]	_	_
9-20	575-576	a	person[37]|person[43]	giv[37]|new[43]	ana	10-2[0_43]
9-21	577-587	co-founder	person[37]|person[43]	giv[37]|new[43]	_	_
9-22	588-591	and	person[37]	giv[37]	_	_
9-23	592-597	chair	person[37]|abstract[44]	giv[37]|new[44]	_	_
9-24	598-600	of	person[37]|abstract[44]	giv[37]|new[44]	_	_
9-25	601-605	Life	person[37]|abstract[44]|organization[47]	giv[37]|new[44]|new[47]	coref	31-21[192_47]
9-26	606-613	Science	person[37]|abstract[44]|organization|organization[47]	giv[37]|new[44]|giv|new[47]	coref	30-11
9-27	614-622	Partners	person[37]|abstract[44]|abstract|organization[47]	giv[37]|new[44]|giv|new[47]	coref	30-9[177_0]
9-28	623-626	LLP	person[37]|abstract[44]|organization[47]	giv[37]|new[44]|new[47]	_	_
9-29	627-628	.	_	_	_	_

#Text=Previously she served as Senior Managing Director of Lehman Brothers , Bear Stearns , and the Peter J. Solomon Company . [ 4 ] [ 5 ]
10-1	629-639	Previously	_	_	_	_
10-2	640-643	she	person	giv	_	_
10-3	644-650	served	_	_	_	_
10-4	651-653	as	_	_	_	_
10-5	654-660	Senior	_	_	_	_
10-6	661-669	Managing	_	_	_	_
10-7	670-678	Director	_	_	_	_
10-8	679-681	of	_	_	_	_
10-9	682-688	Lehman	person[49]	new[49]	coref	11-11[57_49]
10-10	689-697	Brothers	person[49]	new[49]	_	_
10-11	698-699	,	person[49]	new[49]	_	_
10-12	700-704	Bear	person[49]|organization[50]	new[49]|new[50]	coref	25-11[132_50]
10-13	705-712	Stearns	person[49]|organization[50]	new[49]|new[50]	_	_
10-14	713-714	,	_	_	_	_
10-15	715-718	and	_	_	_	_
10-16	719-722	the	organization[52]	new[52]	_	_
10-17	723-728	Peter	person[51]|organization[52]	new[51]|new[52]	coref	26-14[146_51]
10-18	729-731	J.	person[51]|organization[52]	new[51]|new[52]	_	_
10-19	732-739	Solomon	person[51]|organization[52]	new[51]|new[52]	_	_
10-20	740-747	Company	organization[52]	new[52]	_	_
10-21	748-749	.	_	_	_	_
10-22	750-751	[	_	_	_	_
10-23	752-753	4	abstract	giv	coref	12-25
10-24	754-755	]	_	_	_	_
10-25	756-757	[	_	_	_	_
10-26	758-759	5	abstract	giv	coref	12-15
10-27	760-761	]	_	_	_	_

#Text=Tanner was the first woman to become a partner at Lehman Brothers . [ 6 ]
11-1	762-768	Tanner	person	giv	coref	11-3[56_0]
11-2	769-772	was	_	_	_	_
11-3	773-776	the	person[56]	giv[56]	ana	12-1[0_56]
11-4	777-782	first	person[56]	giv[56]	_	_
11-5	783-788	woman	person[56]	giv[56]	_	_
11-6	789-791	to	_	_	_	_
11-7	792-798	become	_	_	_	_
11-8	799-800	a	_	_	_	_
11-9	801-808	partner	_	_	_	_
11-10	809-811	at	_	_	_	_
11-11	812-818	Lehman	person[57]	giv[57]	coref	19-11[95_57]
11-12	819-827	Brothers	person[57]	giv[57]	_	_
11-13	828-829	.	_	_	_	_
11-14	830-831	[	_	_	_	_
11-15	832-833	6	abstract	new	coref	17-15
11-16	834-835	]	_	_	_	_

#Text=She is credited with directing over 130 IPOs for life sciences organizations , [ 5 ] and over 500 mergers and acquisitions . [ 4 ]
12-1	836-839	She	person	giv	coref	14-1[72_0]
12-2	840-842	is	_	_	_	_
12-3	843-851	credited	_	_	_	_
12-4	852-856	with	_	_	_	_
12-5	857-866	directing	_	_	_	_
12-6	867-871	over	organization[60]|abstract[61]	new[60]|new[61]	coref|coref|coref|coref	33-5[200_60]|33-5[201_61]|33-5[200_60]|33-5[201_61]
12-7	872-875	130	organization[60]|abstract[61]	new[60]|new[61]	_	_
12-8	876-880	IPOs	organization[60]|abstract[61]	new[60]|new[61]	_	_
12-9	881-884	for	organization[60]|abstract[61]	new[60]|new[61]	_	_
12-10	885-889	life	organization[60]|abstract[61]|abstract|organization[64]	new[60]|new[61]|new|new[64]	coref|coref	13-1[70_0]|13-1[70_0]
12-11	890-898	sciences	organization[60]|abstract[61]|abstract|organization[64]	new[60]|new[61]|new|new[64]	coref	25-31
12-12	899-912	organizations	organization[60]|abstract[61]|organization[64]	new[60]|new[61]|new[64]	_	_
12-13	913-914	,	abstract[61]	new[61]	_	_
12-14	915-916	[	abstract[61]	new[61]	_	_
12-15	917-918	5	abstract[61]|abstract	new[61]|giv	coref	17-18
12-16	919-920	]	abstract[61]	new[61]	_	_
12-17	921-924	and	abstract[61]	new[61]	_	_
12-18	925-929	over	abstract[61]|event[66]|event[67]	new[61]|new[66]|new[67]	coref|coref|coref|coref	33-12[203_66]|33-12[204_67]|33-12[203_66]|33-12[204_67]
12-19	930-933	500	abstract[61]|event[66]|event[67]	new[61]|new[66]|new[67]	_	_
12-20	934-941	mergers	abstract[61]|event[66]|event[67]	new[61]|new[66]|new[67]	_	_
12-21	942-945	and	abstract[61]|event[67]	new[61]|new[67]	_	_
12-22	946-958	acquisitions	abstract[61]|event[67]|event	new[61]|new[67]|new	_	_
12-23	959-960	.	_	_	_	_
12-24	961-962	[	_	_	_	_
12-25	963-964	4	abstract	giv	coref	31-27
12-26	965-966	]	_	_	_	_

#Text=Early life and education
13-1	967-972	Early	abstract[70]	giv[70]	coref	26-30[0_70]
13-2	973-977	life	abstract[70]	giv[70]	_	_
13-3	978-981	and	_	_	_	_
13-4	982-991	education	abstract	new	_	_

#Text=Mary Catherine Tanner was born to Donald N. Tanner and Marilyn S. Tanner .
14-1	992-996	Mary	person[72]	giv[72]	coref	14-7[73_72]
14-2	997-1006	Catherine	person[72]	giv[72]	_	_
14-3	1007-1013	Tanner	person[72]	giv[72]	_	_
14-4	1014-1017	was	_	_	_	_
14-5	1018-1022	born	_	_	_	_
14-6	1023-1025	to	_	_	_	_
14-7	1026-1032	Donald	person[73]	giv[73]	ana	15-1[0_73]
14-8	1033-1035	N.	person[73]	giv[73]	_	_
14-9	1036-1042	Tanner	person[73]	giv[73]	_	_
14-10	1043-1046	and	person[73]	giv[73]	_	_
14-11	1047-1054	Marilyn	person[73]	giv[73]	_	_
14-12	1055-1057	S.	person[73]	giv[73]	_	_
14-13	1058-1064	Tanner	person[73]	giv[73]	_	_
14-14	1065-1066	.	_	_	_	_

#Text=Her father was a civil engineer .
15-1	1067-1070	Her	person|person[75]	giv|new[75]	coref|coref|coref|coref	15-4[76_75]|17-1|15-4[76_75]|17-1
15-2	1071-1077	father	person[75]	new[75]	_	_
15-3	1078-1081	was	_	_	_	_
15-4	1082-1083	a	person[76]	giv[76]	ana	16-1[0_76]
15-5	1084-1089	civil	person[76]	giv[76]	_	_
15-6	1090-1098	engineer	person[76]	giv[76]	_	_
15-7	1099-1100	.	_	_	_	_

#Text=Her mother was an educator working with learning-disabled children . [ 3 ]
16-1	1101-1104	Her	person|person[78]	giv|new[78]	coref|coref	16-4[79_78]|16-4[79_78]
16-2	1105-1111	mother	person[78]	new[78]	_	_
16-3	1112-1115	was	_	_	_	_
16-4	1116-1118	an	person[79]	giv[79]	_	_
16-5	1119-1127	educator	person[79]	giv[79]	_	_
16-6	1128-1135	working	_	_	_	_
16-7	1136-1140	with	_	_	_	_
16-8	1141-1158	learning-disabled	person[80]	new[80]	ana	22-11[0_80]
16-9	1159-1167	children	person[80]	new[80]	_	_
16-10	1168-1169	.	_	_	_	_
16-11	1170-1171	[	_	_	_	_
16-12	1172-1173	3	abstract	new	coref	22-16
16-13	1174-1175	]	_	_	_	_

#Text=Tanner graduated from Harvard University in 1973 with a B.A. in philosophy , [ 6 ] [ 5 ] magna cum laude . [ 1 ]
17-1	1176-1182	Tanner	person	giv	coref	19-4
17-2	1183-1192	graduated	_	_	_	_
17-3	1193-1197	from	_	_	_	_
17-4	1198-1205	Harvard	organization[83]	new[83]	_	_
17-5	1206-1216	University	organization[83]	new[83]	_	_
17-6	1217-1219	in	_	_	_	_
17-7	1220-1224	1973	time	new	_	_
17-8	1225-1229	with	_	_	_	_
17-9	1230-1231	a	abstract[85]	new[85]	_	_
17-10	1232-1236	B.A.	abstract[85]	new[85]	_	_
17-11	1237-1239	in	abstract[85]	new[85]	_	_
17-12	1240-1250	philosophy	abstract[85]|abstract	new[85]|new	_	_
17-13	1251-1252	,	_	_	_	_
17-14	1253-1254	[	_	_	_	_
17-15	1255-1256	6	abstract	giv	coref	29-20
17-16	1257-1258	]	_	_	_	_
17-17	1259-1260	[	_	_	_	_
17-18	1261-1262	5	abstract	giv	coref	33-9
17-19	1263-1264	]	_	_	_	_
17-20	1265-1270	magna	_	_	_	_
17-21	1271-1274	cum	_	_	_	_
17-22	1275-1280	laude	_	_	_	_
17-23	1281-1282	.	_	_	_	_
17-24	1283-1284	[	_	_	_	_
17-25	1285-1286	1	abstract	giv	coref	23-11
17-26	1287-1288	]	_	_	_	_

#Text=Career
18-1	1289-1295	Career	abstract	new	_	_

#Text=In 1978 , Tanner was included in a team at Lehman Brothers , to handle Humana ' s acquisition of American Medicorp .
19-1	1296-1298	In	_	_	_	_
19-2	1299-1303	1978	time	new	_	_
19-3	1304-1305	,	_	_	_	_
19-4	1306-1312	Tanner	person	giv	coref	21-3
19-5	1313-1316	was	_	_	_	_
19-6	1317-1325	included	_	_	_	_
19-7	1326-1328	in	_	_	_	_
19-8	1329-1330	a	organization[93]	new[93]	coref	20-1[99_93]
19-9	1331-1335	team	organization[93]	new[93]	_	_
19-10	1336-1338	at	organization[93]	new[93]	_	_
19-11	1339-1345	Lehman	organization[93]|person|organization[95]	new[93]|giv|giv[95]	coref|coref|coref|coref	21-9|23-7[117_95]|21-9|23-7[117_95]
19-12	1346-1354	Brothers	organization[93]|organization[95]	new[93]|giv[95]	_	_
19-13	1355-1356	,	_	_	_	_
19-14	1357-1359	to	_	_	_	_
19-15	1360-1366	handle	_	_	_	_
19-16	1367-1373	Humana	organization[96]|event[97]	new[96]|new[97]	_	_
19-17	1374-1375	'	organization[96]|event[97]	new[96]|new[97]	_	_
19-18	1376-1377	s	organization[96]|event[97]	new[96]|new[97]	_	_
19-19	1378-1389	acquisition	event[97]	new[97]	_	_
19-20	1390-1392	of	event[97]	new[97]	_	_
19-21	1393-1401	American	event[97]|organization[98]	new[97]|new[98]	_	_
19-22	1402-1410	Medicorp	event[97]|organization[98]	new[97]|new[98]	_	_
19-23	1411-1412	.	_	_	_	_

#Text=The team was led by Frederick Frank . [ 7 ]
20-1	1413-1416	The	organization[99]	giv[99]	coref	21-6[105_99]
20-2	1417-1421	team	organization[99]	giv[99]	_	_
20-3	1422-1425	was	_	_	_	_
20-4	1426-1429	led	_	_	_	_
20-5	1430-1432	by	_	_	_	_
20-6	1433-1442	Frederick	person[100]	new[100]	coref	21-1[0_100]
20-7	1443-1448	Frank	person[100]	new[100]	_	_
20-8	1449-1450	.	_	_	_	_
20-9	1451-1452	[	_	_	_	_
20-10	1453-1454	7	abstract	new	_	_
20-11	1455-1456	]	_	_	_	_

#Text=Frank convinced Tanner to join his team at Lehman .
21-1	1457-1462	Frank	person	giv	ana	21-6
21-2	1463-1472	convinced	_	_	_	_
21-3	1473-1479	Tanner	person	giv	coref	23-1
21-4	1480-1482	to	_	_	_	_
21-5	1483-1487	join	_	_	_	_
21-6	1488-1491	his	person|organization[105]	giv|giv[105]	coref|coref	23-14|23-14
21-7	1492-1496	team	organization[105]	giv[105]	_	_
21-8	1497-1499	at	_	_	_	_
21-9	1500-1506	Lehman	organization	giv	coref	23-7
21-10	1507-1508	.	_	_	_	_

#Text=Ten years later , on October 15 , 1988 , they were married . [ 3 ]
22-1	1509-1512	Ten	time[107]	new[107]	coref	24-9[124_107]
22-2	1513-1518	years	time[107]	new[107]	_	_
22-3	1519-1524	later	_	_	_	_
22-4	1525-1526	,	_	_	_	_
22-5	1527-1529	on	_	_	_	_
22-6	1530-1537	October	time|time[109]	new|new[109]	coref|coref	28-3[158_109]|28-3[158_109]
22-7	1538-1540	15	time[109]	new[109]	_	_
22-8	1541-1542	,	time[109]	new[109]	_	_
22-9	1543-1547	1988	time[109]|time	new[109]|new	_	_
22-10	1548-1549	,	_	_	_	_
22-11	1550-1554	they	person	giv	_	_
22-12	1555-1559	were	_	_	_	_
22-13	1560-1567	married	_	_	_	_
22-14	1568-1569	.	_	_	_	_
22-15	1570-1571	[	_	_	_	_
22-16	1572-1573	3	abstract	giv	_	_
22-17	1574-1575	]	_	_	_	_

#Text=Tanner became Senior Managing Director of Lehman Brothers , [ 1 ] while Frank became vice chair of Lehman Brothers .
23-1	1576-1582	Tanner	person	giv	coref	24-14
23-2	1583-1589	became	_	_	_	_
23-3	1590-1596	Senior	person[115]	new[115]	coref	25-7[0_115]
23-4	1597-1605	Managing	organization|person[115]	giv|new[115]	coref	25-8
23-5	1606-1614	Director	person[115]	new[115]	_	_
23-6	1615-1617	of	person[115]	new[115]	_	_
23-7	1618-1624	Lehman	person[115]|person|organization[117]	new[115]|giv|giv[117]	coref|coref|coref|coref	23-19|23-19[121_117]|23-19|23-19[121_117]
23-8	1625-1633	Brothers	person[115]|organization[117]	new[115]|giv[117]	_	_
23-9	1634-1635	,	_	_	_	_
23-10	1636-1637	[	_	_	_	_
23-11	1638-1639	1	abstract	giv	coref	43-25
23-12	1640-1641	]	_	_	_	_
23-13	1642-1647	while	_	_	_	_
23-14	1648-1653	Frank	person	giv	coref	24-1[122_0]
23-15	1654-1660	became	_	_	_	_
23-16	1661-1665	vice	_	_	_	_
23-17	1666-1671	chair	_	_	_	_
23-18	1672-1674	of	_	_	_	_
23-19	1675-1681	Lehman	person|organization[121]	giv|giv[121]	coref|coref	24-7|24-7
23-20	1682-1690	Brothers	organization[121]	giv[121]	_	_
23-21	1691-1692	.	_	_	_	_

#Text=Frank and Tanner worked together at Lehman for over ten years , until Tanner took time off to have a child . [ 2 ]
24-1	1693-1698	Frank	person[122]	giv[122]	coref	26-11[145_122]
24-2	1699-1702	and	person[122]	giv[122]	_	_
24-3	1703-1709	Tanner	person[122]	giv[122]	_	_
24-4	1710-1716	worked	_	_	_	_
24-5	1717-1725	together	_	_	_	_
24-6	1726-1728	at	_	_	_	_
24-7	1729-1735	Lehman	organization	giv	_	_
24-8	1736-1739	for	_	_	_	_
24-9	1740-1744	over	time[124]	giv[124]	_	_
24-10	1745-1748	ten	time[124]	giv[124]	_	_
24-11	1749-1754	years	time[124]	giv[124]	_	_
24-12	1755-1756	,	_	_	_	_
24-13	1757-1762	until	_	_	_	_
24-14	1763-1769	Tanner	person	giv	coref	25-1
24-15	1770-1774	took	_	_	_	_
24-16	1775-1779	time	_	_	_	_
24-17	1780-1783	off	_	_	_	_
24-18	1784-1786	to	_	_	_	_
24-19	1787-1791	have	_	_	_	_
24-20	1792-1793	a	person[126]	new[126]	_	_
24-21	1794-1799	child	person[126]	new[126]	_	_
24-22	1800-1801	.	_	_	_	_
24-23	1802-1803	[	_	_	_	_
24-24	1804-1805	2	abstract	new	coref	25-18
24-25	1806-1807	]	_	_	_	_

#Text=Tanner returned to work as the Senior Managing Director at Bear Stearns as of 2000 , [ 2 ] and retired from Bear Stearns in 2004 , to found Life Sciences Partners . [ 8 ]
25-1	1808-1814	Tanner	person	giv	coref	26-8[144_0]
25-2	1815-1823	returned	_	_	_	_
25-3	1824-1826	to	_	_	_	_
25-4	1827-1831	work	abstract	new	_	_
25-5	1832-1834	as	_	_	_	_
25-6	1835-1838	the	_	_	_	_
25-7	1839-1845	Senior	person	giv	_	_
25-8	1846-1854	Managing	organization	giv	coref	29-5
25-9	1855-1863	Director	_	_	_	_
25-10	1864-1866	at	_	_	_	_
25-11	1867-1871	Bear	organization[132]	giv[132]	coref	25-23[135_132]
25-12	1872-1879	Stearns	organization[132]	giv[132]	_	_
25-13	1880-1882	as	_	_	_	_
25-14	1883-1885	of	_	_	_	_
25-15	1886-1890	2000	time	new	_	_
25-16	1891-1892	,	_	_	_	_
25-17	1893-1894	[	_	_	_	_
25-18	1895-1896	2	abstract	giv	_	_
25-19	1897-1898	]	_	_	_	_
25-20	1899-1902	and	_	_	_	_
25-21	1903-1910	retired	_	_	_	_
25-22	1911-1915	from	_	_	_	_
25-23	1916-1920	Bear	organization[135]	giv[135]	coref	36-3[235_135]
25-24	1921-1928	Stearns	organization[135]	giv[135]	_	_
25-25	1929-1931	in	_	_	_	_
25-26	1932-1936	2004	time	new	_	_
25-27	1937-1938	,	_	_	_	_
25-28	1939-1941	to	_	_	_	_
25-29	1942-1947	found	_	_	_	_
25-30	1948-1952	Life	time|abstract[139]	giv|new[139]	coref|coref	30-10|30-10
25-31	1953-1961	Sciences	person|abstract[139]	giv|new[139]	coref	26-30[151_0]
25-32	1962-1970	Partners	abstract[139]	new[139]	_	_
25-33	1971-1972	.	_	_	_	_
25-34	1973-1974	[	_	_	_	_
25-35	1975-1976	8	abstract	new	_	_
25-36	1977-1978	]	_	_	_	_

#Text=As of March 18 , 2009 , Mary Tanner and Frederick Frank joined Peter J. Solomon , of PJ SOLOMON to form a new practice focusing on pharmaceuticals and life sciences . [ 9 ]
26-1	1979-1981	As	_	_	_	_
26-2	1982-1984	of	_	_	_	_
26-3	1985-1990	March	time|time[142]	new|new[142]	coref|coref	43-13[0_142]|43-13[0_142]
26-4	1991-1993	18	time[142]	new[142]	_	_
26-5	1994-1995	,	time[142]	new[142]	_	_
26-6	1996-2000	2009	time[142]|time	new[142]|new	_	_
26-7	2001-2002	,	_	_	_	_
26-8	2003-2007	Mary	person[144]	giv[144]	coref	27-1[0_144]
26-9	2008-2014	Tanner	person[144]	giv[144]	_	_
26-10	2015-2018	and	person[144]	giv[144]	_	_
26-11	2019-2028	Frederick	person[144]|person[145]	giv[144]|giv[145]	coref	27-12[0_145]
26-12	2029-2034	Frank	person[144]|person[145]	giv[144]|giv[145]	_	_
26-13	2035-2041	joined	_	_	_	_
26-14	2042-2047	Peter	person[146]	giv[146]	coref	27-7[154_146]
26-15	2048-2050	J.	person[146]	giv[146]	_	_
26-16	2051-2058	Solomon	person[146]	giv[146]	_	_
26-17	2059-2060	,	_	_	_	_
26-18	2061-2063	of	_	_	_	_
26-19	2064-2066	PJ	organization[147]	new[147]	_	_
26-20	2067-2074	SOLOMON	organization[147]	new[147]	_	_
26-21	2075-2077	to	_	_	_	_
26-22	2078-2082	form	_	_	_	_
26-23	2083-2084	a	organization[148]	new[148]	_	_
26-24	2085-2088	new	organization[148]	new[148]	_	_
26-25	2089-2097	practice	organization[148]	new[148]	_	_
26-26	2098-2106	focusing	_	_	_	_
26-27	2107-2109	on	_	_	_	_
26-28	2110-2125	pharmaceuticals	substance[149]	giv[149]	_	_
26-29	2126-2129	and	substance[149]	giv[149]	_	_
26-30	2130-2134	life	substance[149]|abstract|abstract[151]	giv[149]|giv|giv[151]	coref|coref|coref|coref	33-18|33-18[207_151]|33-18|33-18[207_151]
26-31	2135-2143	sciences	substance[149]|abstract[151]	giv[149]|giv[151]	_	_
26-32	2144-2145	.	_	_	_	_
26-33	2146-2147	[	_	_	_	_
26-34	2148-2149	9	time	new	coref	36-22
26-35	2150-2151	]	_	_	_	_

#Text=Tanner became a managing director at Peter J. Solomon , while Frank became a vice chairman . [ 10 ]
27-1	2152-2158	Tanner	person	giv	coref	28-8[160_0]
27-2	2159-2165	became	_	_	_	_
27-3	2166-2167	a	_	_	_	_
27-4	2168-2176	managing	_	_	_	_
27-5	2177-2185	director	_	_	_	_
27-6	2186-2188	at	_	_	_	_
27-7	2189-2194	Peter	person[154]	giv[154]	_	_
27-8	2195-2197	J.	person[154]	giv[154]	_	_
27-9	2198-2205	Solomon	person[154]	giv[154]	_	_
27-10	2206-2207	,	_	_	_	_
27-11	2208-2213	while	_	_	_	_
27-12	2214-2219	Frank	person	giv	coref	28-11[161_0]
27-13	2220-2226	became	_	_	_	_
27-14	2227-2228	a	_	_	_	_
27-15	2229-2233	vice	_	_	_	_
27-16	2234-2242	chairman	_	_	_	_
27-17	2243-2244	.	_	_	_	_
27-18	2245-2246	[	_	_	_	_
27-19	2247-2249	10	abstract	new	_	_
27-20	2250-2251	]	_	_	_	_

#Text=As of January 15 , 2013 , Mary Tanner and Frederick Frank joined Burrill & Company . [ 11 ]
28-1	2252-2254	As	_	_	_	_
28-2	2255-2257	of	_	_	_	_
28-3	2258-2265	January	time|time[158]	new|giv[158]	coref|coref	41-30[0_158]|41-30[0_158]
28-4	2266-2268	15	time[158]	giv[158]	_	_
28-5	2269-2270	,	time[158]	giv[158]	_	_
28-6	2271-2275	2013	time[158]|time	giv[158]|new	_	_
28-7	2276-2277	,	_	_	_	_
28-8	2278-2282	Mary	person[160]	giv[160]	coref	29-1[0_160]
28-9	2283-2289	Tanner	person[160]	giv[160]	_	_
28-10	2290-2293	and	person[160]	giv[160]	_	_
28-11	2294-2303	Frederick	person[160]|person[161]	giv[160]|giv[161]	coref	35-5[227_161]
28-12	2304-2309	Frank	person[160]|person[161]	giv[160]|giv[161]	_	_
28-13	2310-2316	joined	_	_	_	_
28-14	2317-2324	Burrill	person	new	coref	29-8
28-15	2325-2326	&	_	_	_	_
28-16	2327-2334	Company	_	_	_	_
28-17	2335-2336	.	_	_	_	_
28-18	2337-2338	[	_	_	_	_
28-19	2339-2341	11	abstract	new	coref	29-17
28-20	2342-2343	]	_	_	_	_

#Text=Tanner became the Senior Managing Director of Burrill Securities and of Burrill & Company . [ 11 ] [ 6 ]
29-1	2344-2350	Tanner	person	giv	coref	30-5[173_0]
29-2	2351-2357	became	_	_	_	_
29-3	2358-2361	the	person[166]	new[166]	_	_
29-4	2362-2368	Senior	person[166]	new[166]	_	_
29-5	2369-2377	Managing	organization|person[166]	giv|new[166]	coref	31-4
29-6	2378-2386	Director	person[166]	new[166]	_	_
29-7	2387-2389	of	person[166]	new[166]	_	_
29-8	2390-2397	Burrill	person[166]|person|organization[168]	new[166]|giv|new[168]	coref|coref	29-12|29-12
29-9	2398-2408	Securities	person[166]|organization[168]	new[166]|new[168]	_	_
29-10	2409-2412	and	_	_	_	_
29-11	2413-2415	of	_	_	_	_
29-12	2416-2423	Burrill	person	giv	_	_
29-13	2424-2425	&	_	_	_	_
29-14	2426-2433	Company	_	_	_	_
29-15	2434-2435	.	_	_	_	_
29-16	2436-2437	[	_	_	_	_
29-17	2438-2440	11	abstract	giv	coref	34-39
29-18	2441-2442	]	_	_	_	_
29-19	2443-2444	[	_	_	_	_
29-20	2445-2446	6	abstract	giv	coref	32-14
29-21	2447-2448	]	_	_	_	_

#Text=As of 2014 , Tanner and Frank founded EVOLUTION Life Science Partners ( ELSP ) . [ 12 ]
30-1	2449-2451	As	_	_	_	_
30-2	2452-2454	of	_	_	_	_
30-3	2455-2459	2014	time	giv	_	_
30-4	2460-2461	,	_	_	_	_
30-5	2462-2468	Tanner	person[173]	giv[173]	coref	31-1[0_173]
30-6	2469-2472	and	person[173]	giv[173]	_	_
30-7	2473-2478	Frank	person[173]	giv[173]	_	_
30-8	2479-2486	founded	_	_	_	_
30-9	2487-2496	EVOLUTION	abstract|abstract[177]	giv|giv[177]	coref|coref|coref|coref	30-14[0_177]|31-7|30-14[0_177]|31-7
30-10	2497-2501	Life	time|abstract[177]	giv|giv[177]	coref	31-8
30-11	2502-2509	Science	organization|abstract[177]	giv|giv[177]	coref	31-9
30-12	2510-2518	Partners	abstract[177]	giv[177]	_	_
30-13	2519-2520	(	_	_	_	_
30-14	2521-2525	ELSP	abstract	giv	coref	31-7[186_0]
30-15	2526-2527	)	_	_	_	_
30-16	2528-2529	.	_	_	_	_
30-17	2530-2531	[	_	_	_	_
30-18	2532-2534	12	abstract	new	_	_
30-19	2535-2536	]	_	_	_	_

#Text=Tanner is Senior Managing Director of EVOLUTION Life Science Partners ( ELSP ) , and a co-founder and chair of Life Science Partners LLP . [ 4 ]
31-1	2537-2543	Tanner	person	giv	coref	31-3[182_0]
31-2	2544-2546	is	_	_	_	_
31-3	2547-2553	Senior	person[182]	giv[182]	coref	32-1[0_182]
31-4	2554-2562	Managing	organization|person[182]	giv|giv[182]	_	_
31-5	2563-2571	Director	person[182]	giv[182]	_	_
31-6	2572-2574	of	person[182]	giv[182]	_	_
31-7	2575-2584	EVOLUTION	person[182]|abstract|abstract[186]	giv[182]|giv|giv[186]	coref|coref	31-12[0_186]|31-12[0_186]
31-8	2585-2589	Life	person[182]|time|abstract[186]	giv[182]|giv|giv[186]	coref	31-21
31-9	2590-2597	Science	person[182]|organization|abstract[186]	giv[182]|giv|giv[186]	coref	31-22
31-10	2598-2606	Partners	person[182]|abstract[186]	giv[182]|giv[186]	_	_
31-11	2607-2608	(	person[182]	giv[182]	_	_
31-12	2609-2613	ELSP	person[182]|abstract	giv[182]|giv	_	_
31-13	2614-2615	)	person[182]	giv[182]	_	_
31-14	2616-2617	,	person[182]	giv[182]	_	_
31-15	2618-2621	and	person[182]	giv[182]	_	_
31-16	2622-2623	a	person[182]|person[188]	giv[182]|new[188]	_	_
31-17	2624-2634	co-founder	person[182]|person[188]	giv[182]|new[188]	_	_
31-18	2635-2638	and	person[182]	giv[182]	_	_
31-19	2639-2644	chair	person[182]|abstract[189]	giv[182]|new[189]	_	_
31-20	2645-2647	of	person[182]|abstract[189]	giv[182]|new[189]	_	_
31-21	2648-2652	Life	person[182]|abstract[189]|time|organization[192]	giv[182]|new[189]|giv|giv[192]	_	_
31-22	2653-2660	Science	person[182]|abstract[189]|organization|organization[192]	giv[182]|new[189]|giv|giv[192]	_	_
31-23	2661-2669	Partners	person[182]|abstract[189]|organization[192]	giv[182]|new[189]|giv[192]	_	_
31-24	2670-2673	LLP	person[182]|abstract[189]|organization[192]	giv[182]|new[189]|giv[192]	_	_
31-25	2674-2675	.	_	_	_	_
31-26	2676-2677	[	_	_	_	_
31-27	2678-2679	4	abstract	giv	coref	33-23
31-28	2680-2681	]	_	_	_	_

#Text=Tanner has served on numerous advisory groups and boards of directors . [ 6 ]
32-1	2682-2688	Tanner	person	giv	ana	33-1
32-2	2689-2692	has	_	_	_	_
32-3	2693-2699	served	_	_	_	_
32-4	2700-2702	on	_	_	_	_
32-5	2703-2711	numerous	person[195]	new[195]	_	_
32-6	2712-2720	advisory	person[195]	new[195]	_	_
32-7	2721-2727	groups	person[195]	new[195]	_	_
32-8	2728-2731	and	_	_	_	_
32-9	2732-2738	boards	organization[196]	new[196]	_	_
32-10	2739-2741	of	organization[196]	new[196]	_	_
32-11	2742-2751	directors	organization[196]|person	new[196]|new	_	_
32-12	2752-2753	.	_	_	_	_
32-13	2754-2755	[	_	_	_	_
32-14	2756-2757	6	abstract	giv	_	_
32-15	2758-2759	]	_	_	_	_

#Text=She is credited with over 130 IPOs [ 5 ] and over 500 mergers and acquisitions for life sciences organizations . [ 4 ]
33-1	2760-2763	She	person	giv	ana	34-2
33-2	2764-2766	is	_	_	_	_
33-3	2767-2775	credited	_	_	_	_
33-4	2776-2780	with	_	_	_	_
33-5	2781-2785	over	organization[200]|abstract[201]	giv[200]|giv[201]	_	_
33-6	2786-2789	130	organization[200]|abstract[201]	giv[200]|giv[201]	_	_
33-7	2790-2794	IPOs	organization[200]|abstract[201]	giv[200]|giv[201]	_	_
33-8	2795-2796	[	abstract[201]	giv[201]	_	_
33-9	2797-2798	5	abstract[201]|abstract	giv[201]|giv	coref	34-36
33-10	2799-2800	]	abstract[201]	giv[201]	_	_
33-11	2801-2804	and	abstract[201]	giv[201]	_	_
33-12	2805-2809	over	abstract[201]|event[203]|event[204]	giv[201]|giv[203]|giv[204]	_	_
33-13	2810-2813	500	abstract[201]|event[203]|event[204]	giv[201]|giv[203]|giv[204]	_	_
33-14	2814-2821	mergers	abstract[201]|event[203]|event[204]	giv[201]|giv[203]|giv[204]	_	_
33-15	2822-2825	and	abstract[201]|event[204]	giv[201]|giv[204]	_	_
33-16	2826-2838	acquisitions	abstract[201]|event[204]|abstract[205]	giv[201]|giv[204]|new[205]	_	_
33-17	2839-2842	for	abstract[201]|event[204]|abstract[205]	giv[201]|giv[204]|new[205]	_	_
33-18	2843-2847	life	abstract[201]|event[204]|abstract[205]|abstract|abstract[207]|organization[208]	giv[201]|giv[204]|new[205]|giv|giv[207]|new[208]	_	_
33-19	2848-2856	sciences	abstract[201]|event[204]|abstract[205]|abstract[207]|organization[208]	giv[201]|giv[204]|new[205]|giv[207]|new[208]	_	_
33-20	2857-2870	organizations	abstract[201]|event[204]|abstract[205]|organization[208]	giv[201]|giv[204]|new[205]|new[208]	_	_
33-21	2871-2872	.	_	_	_	_
33-22	2873-2874	[	_	_	_	_
33-23	2875-2876	4	abstract	giv	_	_
33-24	2877-2878	]	_	_	_	_

#Text=During her time at Lehmann , Tanner represented Rhône-Poulenc when it acquired Rorer for $ 1.8 billion in 1990 , and in 1995 represented Rhône-Poulenc Rorer when it acquired Fisons for £1.8 billion . [ 5 ] [ 11 ]
34-1	2879-2885	During	_	_	_	_
34-2	2886-2889	her	person|person[211]	giv|new[211]	coref|coref	34-7|34-7
34-3	2890-2894	time	person[211]	new[211]	_	_
34-4	2895-2897	at	person[211]	new[211]	_	_
34-5	2898-2905	Lehmann	person[211]|organization	new[211]|new	_	_
34-6	2906-2907	,	_	_	_	_
34-7	2908-2914	Tanner	person	giv	coref	35-3[226_0]
34-8	2915-2926	represented	_	_	_	_
34-9	2927-2940	Rhône-Poulenc	organization	new	ana	34-11
34-10	2941-2945	when	_	_	_	_
34-11	2946-2948	it	organization	giv	coref	34-25[220_0]
34-12	2949-2957	acquired	_	_	_	_
34-13	2958-2963	Rorer	organization	new	_	_
34-14	2964-2967	for	_	_	_	_
34-15	2968-2969	$	_	_	_	_
34-16	2970-2973	1.8	quantity[217]	new[217]	_	_
34-17	2974-2981	billion	quantity[217]	new[217]	_	_
34-18	2982-2984	in	_	_	_	_
34-19	2985-2989	1990	time	new	_	_
34-20	2990-2991	,	_	_	_	_
34-21	2992-2995	and	_	_	_	_
34-22	2996-2998	in	_	_	_	_
34-23	2999-3003	1995	time	new	ana	35-12
34-24	3004-3015	represented	_	_	_	_
34-25	3016-3029	Rhône-Poulenc	organization[220]	giv[220]	ana	34-28[0_220]
34-26	3030-3035	Rorer	organization[220]	giv[220]	_	_
34-27	3036-3040	when	_	_	_	_
34-28	3041-3043	it	organization	giv	_	_
34-29	3044-3052	acquired	_	_	_	_
34-30	3053-3059	Fisons	organization	new	_	_
34-31	3060-3063	for	_	_	_	_
34-32	3064-3068	£1.8	quantity[223]	new[223]	_	_
34-33	3069-3076	billion	quantity[223]	new[223]	_	_
34-34	3077-3078	.	_	_	_	_
34-35	3079-3080	[	_	_	_	_
34-36	3081-3082	5	abstract	giv	coref	37-15
34-37	3083-3084	]	_	_	_	_
34-38	3085-3086	[	_	_	_	_
34-39	3087-3089	11	abstract	giv	coref	35-28
34-40	3090-3091	]	_	_	_	_

#Text=Together , Tanner and Frederick Frank represented Marion Merrell Dow in its merger with Hoechst AG , forming Hoechst Marion Roussel , Inc. in 1995 . [ 11 ]
35-1	3092-3100	Together	_	_	_	_
35-2	3101-3102	,	_	_	_	_
35-3	3103-3109	Tanner	person[226]	giv[226]	coref	36-6[0_226]
35-4	3110-3113	and	person[226]	giv[226]	_	_
35-5	3114-3123	Frederick	person[226]|person[227]	giv[226]|giv[227]	coref	41-36[284_227]
35-6	3124-3129	Frank	person[226]|person[227]	giv[226]|giv[227]	_	_
35-7	3130-3141	represented	_	_	_	_
35-8	3142-3148	Marion	organization[228]	new[228]	_	_
35-9	3149-3156	Merrell	organization[228]	new[228]	_	_
35-10	3157-3160	Dow	organization[228]	new[228]	_	_
35-11	3161-3163	in	_	_	_	_
35-12	3164-3167	its	time|event[230]	giv|new[230]	coref|coref	35-25|35-25
35-13	3168-3174	merger	event[230]	new[230]	_	_
35-14	3175-3179	with	event[230]	new[230]	_	_
35-15	3180-3187	Hoechst	event[230]|organization[231]	new[230]|new[231]	_	_
35-16	3188-3190	AG	event[230]|organization[231]	new[230]|new[231]	_	_
35-17	3191-3192	,	_	_	_	_
35-18	3193-3200	forming	_	_	_	_
35-19	3201-3208	Hoechst	organization[232]	new[232]	_	_
35-20	3209-3215	Marion	organization[232]	new[232]	_	_
35-21	3216-3223	Roussel	organization[232]	new[232]	_	_
35-22	3224-3225	,	_	_	_	_
35-23	3226-3230	Inc.	_	_	_	_
35-24	3231-3233	in	_	_	_	_
35-25	3234-3238	1995	time	giv	_	_
35-26	3239-3240	.	_	_	_	_
35-27	3241-3242	[	_	_	_	_
35-28	3243-3245	11	abstract	giv	coref	37-18
35-29	3246-3247	]	_	_	_	_

#Text=While at Bear Stearns , Tanner represented Pfizer when it acquired Pharmacia for $ 60 billion ( 2002-2003 ) . [ 9 ] [ 13 ]
36-1	3248-3253	While	_	_	_	_
36-2	3254-3256	at	_	_	_	_
36-3	3257-3261	Bear	organization[235]	giv[235]	_	_
36-4	3262-3269	Stearns	organization[235]	giv[235]	_	_
36-5	3270-3271	,	_	_	_	_
36-6	3272-3278	Tanner	person	giv	ana	37-1
36-7	3279-3290	represented	_	_	_	_
36-8	3291-3297	Pfizer	organization	new	ana	36-10
36-9	3298-3302	when	_	_	_	_
36-10	3303-3305	it	organization	giv	_	_
36-11	3306-3314	acquired	_	_	_	_
36-12	3315-3324	Pharmacia	organization	new	_	_
36-13	3325-3328	for	_	_	_	_
36-14	3329-3330	$	_	_	_	_
36-15	3331-3333	60	quantity[240]	new[240]	_	_
36-16	3334-3341	billion	quantity[240]	new[240]	_	_
36-17	3342-3343	(	_	_	_	_
36-18	3344-3353	2002-2003	time	new	_	_
36-19	3354-3355	)	_	_	_	_
36-20	3356-3357	.	_	_	_	_
36-21	3358-3359	[	_	_	_	_
36-22	3360-3361	9	time	giv	coref	41-57[288_0]
36-23	3362-3363	]	_	_	_	_
36-24	3364-3365	[	_	_	_	_
36-25	3366-3368	13	abstract	new	_	_
36-26	3369-3370	]	_	_	_	_

#Text=She also represented Amgen when it acquired Immunex for $ 16 billion . [ 5 ] [ 11 ]
37-1	3371-3374	She	person	giv	coref	39-9[253_0]
37-2	3375-3379	also	_	_	_	_
37-3	3380-3391	represented	_	_	_	_
37-4	3392-3397	Amgen	organization	new	ana	37-6
37-5	3398-3402	when	_	_	_	_
37-6	3403-3405	it	organization	giv	_	_
37-7	3406-3414	acquired	_	_	_	_
37-8	3415-3422	Immunex	object	new	_	_
37-9	3423-3426	for	_	_	_	_
37-10	3427-3428	$	_	_	_	_
37-11	3429-3431	16	quantity[248]	new[248]	_	_
37-12	3432-3439	billion	quantity[248]	new[248]	_	_
37-13	3440-3441	.	_	_	_	_
37-14	3442-3443	[	_	_	_	_
37-15	3444-3445	5	abstract	giv	coref	40-31
37-16	3446-3447	]	_	_	_	_
37-17	3448-3449	[	_	_	_	_
37-18	3450-3452	11	abstract	giv	_	_
37-19	3453-3454	]	_	_	_	_

#Text=Philanthropy
38-1	3455-3467	Philanthropy	abstract	new	_	_

#Text=As of October , 1997 , the non-profit Tanner Frank Foundation of New York City was granted charitable status . [ 14 ]
39-1	3468-3470	As	_	_	_	_
39-2	3471-3473	of	_	_	_	_
39-3	3474-3481	October	_	_	_	_
39-4	3482-3483	,	_	_	_	_
39-5	3484-3488	1997	time	new	_	_
39-6	3489-3490	,	_	_	_	_
39-7	3491-3494	the	organization[254]	new[254]	_	_
39-8	3495-3505	non-profit	organization[254]	new[254]	_	_
39-9	3506-3512	Tanner	person[253]|organization[254]	giv[253]|new[254]	coref	40-1[0_253]
39-10	3513-3518	Frank	person[253]|organization[254]	giv[253]|new[254]	_	_
39-11	3519-3529	Foundation	organization[254]	new[254]	_	_
39-12	3530-3532	of	organization[254]	new[254]	_	_
39-13	3533-3536	New	organization[254]|place[255]	new[254]|new[255]	_	_
39-14	3537-3541	York	organization[254]|place[255]	new[254]|new[255]	_	_
39-15	3542-3546	City	organization[254]|place[255]	new[254]|new[255]	_	_
39-16	3547-3550	was	_	_	_	_
39-17	3551-3558	granted	_	_	_	_
39-18	3559-3569	charitable	organization|abstract[257]	new|new[257]	_	_
39-19	3570-3576	status	abstract[257]	new[257]	_	_
39-20	3577-3578	.	_	_	_	_
39-21	3579-3580	[	_	_	_	_
39-22	3581-3583	14	quantity	new	coref	41-12
39-23	3584-3585	]	_	_	_	_

#Text=Tanner has served on the Dean 's Council for the Yale School of Medicine and on the advisory board for the Yale School of Management ( SOM ) . [ 5 ]
40-1	3586-3592	Tanner	person	giv	coref	41-1[271_0]
40-2	3593-3596	has	_	_	_	_
40-3	3597-3603	served	_	_	_	_
40-4	3604-3606	on	_	_	_	_
40-5	3607-3610	the	organization[261]	new[261]	_	_
40-6	3611-3615	Dean	person[260]|organization[261]	new[260]|new[261]	_	_
40-7	3616-3618	's	person[260]|organization[261]	new[260]|new[261]	_	_
40-8	3619-3626	Council	organization[261]	new[261]	_	_
40-9	3627-3630	for	organization[261]	new[261]	_	_
40-10	3631-3634	the	organization[261]|organization[263]	new[261]|new[263]	coref	41-23[280_263]
40-11	3635-3639	Yale	organization[261]|place|organization[263]	new[261]|new|new[263]	coref	40-22
40-12	3640-3646	School	organization[261]|organization[263]	new[261]|new[263]	_	_
40-13	3647-3649	of	organization[261]|organization[263]	new[261]|new[263]	_	_
40-14	3650-3658	Medicine	organization[261]|organization[263]|abstract	new[261]|new[263]|new	coref	41-27
40-15	3659-3662	and	_	_	_	_
40-16	3663-3665	on	_	_	_	_
40-17	3666-3669	the	abstract[265]	new[265]	_	_
40-18	3670-3678	advisory	abstract[265]	new[265]	_	_
40-19	3679-3684	board	abstract[265]	new[265]	_	_
40-20	3685-3688	for	abstract[265]	new[265]	_	_
40-21	3689-3692	the	abstract[265]|organization[267]	new[265]|new[267]	appos	40-27[0_267]
40-22	3693-3697	Yale	abstract[265]|place|organization[267]	new[265]|giv|new[267]	coref	41-9
40-23	3698-3704	School	abstract[265]|organization[267]	new[265]|new[267]	_	_
40-24	3705-3707	of	abstract[265]|organization[267]	new[265]|new[267]	_	_
40-25	3708-3718	Management	abstract[265]|organization[267]|person	new[265]|new[267]|new	_	_
40-26	3719-3720	(	_	_	_	_
40-27	3721-3724	SOM	organization	giv	_	_
40-28	3725-3726	)	_	_	_	_
40-29	3727-3728	.	_	_	_	_
40-30	3729-3730	[	_	_	_	_
40-31	3731-3732	5	abstract	giv	_	_
40-32	3733-3734	]	_	_	_	_

#Text=Tanner and Frank have made multiple gifts to Yale , [ 14 ] including early career support of researchers in autism at the Yale School of Medicine , [ 15 ] and the creation of the Frank and Tanner Professor of Management at the Yale School of Management , to which Olav Sorenson was appointed on April 9 , 2012 . [ 16 ]
41-1	3735-3741	Tanner	person[271]	giv[271]	coref	41-36[285_271]
41-2	3742-3745	and	person[271]	giv[271]	_	_
41-3	3746-3751	Frank	person[271]	giv[271]	_	_
41-4	3752-3756	have	_	_	_	_
41-5	3757-3761	made	_	_	_	_
41-6	3762-3770	multiple	object[272]	new[272]	_	_
41-7	3771-3776	gifts	object[272]	new[272]	_	_
41-8	3777-3779	to	object[272]	new[272]	_	_
41-9	3780-3784	Yale	object[272]|organization	new[272]|giv	coref	41-24
41-10	3785-3786	,	_	_	_	_
41-11	3787-3788	[	_	_	_	_
41-12	3789-3791	14	quantity	giv	_	_
41-13	3792-3793	]	_	_	_	_
41-14	3794-3803	including	_	_	_	_
41-15	3804-3809	early	abstract[276]	new[276]	_	_
41-16	3810-3816	career	person|abstract[276]	new|new[276]	_	_
41-17	3817-3824	support	abstract[276]	new[276]	_	_
41-18	3825-3827	of	abstract[276]	new[276]	_	_
41-19	3828-3839	researchers	abstract[276]|person[277]	new[276]|new[277]	_	_
41-20	3840-3842	in	abstract[276]|person[277]	new[276]|new[277]	_	_
41-21	3843-3849	autism	abstract[276]|person[277]|abstract[278]	new[276]|new[277]|new[278]	_	_
41-22	3850-3852	at	abstract[276]|person[277]|abstract[278]	new[276]|new[277]|new[278]	_	_
41-23	3853-3856	the	abstract[276]|person[277]|abstract[278]|organization[280]	new[276]|new[277]|new[278]|giv[280]	_	_
41-24	3857-3861	Yale	abstract[276]|person[277]|abstract[278]|place|organization[280]	new[276]|new[277]|new[278]|giv|giv[280]	_	_
41-25	3862-3868	School	abstract[276]|person[277]|abstract[278]|organization[280]	new[276]|new[277]|new[278]|giv[280]	_	_
41-26	3869-3871	of	abstract[276]|person[277]|abstract[278]|organization[280]	new[276]|new[277]|new[278]|giv[280]	_	_
41-27	3872-3880	Medicine	abstract[276]|person[277]|abstract[278]|organization[280]|abstract	new[276]|new[277]|new[278]|giv[280]|giv	_	_
41-28	3881-3882	,	_	_	_	_
41-29	3883-3884	[	_	_	_	_
41-30	3885-3887	15	time	giv	_	_
41-31	3888-3889	]	_	_	_	_
41-32	3890-3893	and	_	_	_	_
41-33	3894-3897	the	event[283]	new[283]	_	_
41-34	3898-3906	creation	event[283]	new[283]	_	_
41-35	3907-3909	of	event[283]	new[283]	_	_
41-36	3910-3913	the	event[283]|person[284]|person[285]	new[283]|giv[284]|giv[285]	_	_
41-37	3914-3919	Frank	event[283]|person[284]|person[285]	new[283]|giv[284]|giv[285]	_	_
41-38	3920-3923	and	event[283]|person[285]	new[283]|giv[285]	_	_
41-39	3924-3930	Tanner	event[283]|person[285]	new[283]|giv[285]	_	_
41-40	3931-3940	Professor	event[283]|person[285]	new[283]|giv[285]	_	_
41-41	3941-3943	of	event[283]|person[285]	new[283]|giv[285]	_	_
41-42	3944-3954	Management	event[283]|person[285]	new[283]|giv[285]	_	_
41-43	3955-3957	at	event[283]|person[285]	new[283]|giv[285]	_	_
41-44	3958-3961	the	event[283]|person[285]	new[283]|giv[285]	_	_
41-45	3962-3966	Yale	event[283]|person[285]	new[283]|giv[285]	_	_
41-46	3967-3973	School	event[283]|person[285]	new[283]|giv[285]	_	_
41-47	3974-3976	of	event[283]|person[285]	new[283]|giv[285]	_	_
41-48	3977-3987	Management	event[283]|person[285]	new[283]|giv[285]	_	_
41-49	3988-3989	,	_	_	_	_
41-50	3990-3992	to	_	_	_	_
41-51	3993-3998	which	_	_	_	_
41-52	3999-4003	Olav	person[286]	new[286]	_	_
41-53	4004-4012	Sorenson	person[286]	new[286]	_	_
41-54	4013-4016	was	_	_	_	_
41-55	4017-4026	appointed	_	_	_	_
41-56	4027-4029	on	_	_	_	_
41-57	4030-4035	April	time|time[288]	new|giv[288]	_	_
41-58	4036-4037	9	time[288]	giv[288]	_	_
41-59	4038-4039	,	time[288]	giv[288]	_	_
41-60	4040-4044	2012	time[288]|time	giv[288]|new	coref	43-1
41-61	4045-4046	.	_	_	_	_
41-62	4047-4048	[	_	_	_	_
41-63	4049-4051	16	abstract	new	_	_
41-64	4052-4053	]	_	_	_	_

#Text=Awards and honors
42-1	4054-4060	Awards	abstract	new	_	_
42-2	4061-4064	and	_	_	_	_
42-3	4065-4071	honors	abstract	new	_	_

#Text=2012 , Oracle award , Springboard Enterprises , [ 17 ] [ 18 ] for professional accomplishment and mentoring of women entrepreneurs . [ 1 ]
43-1	4072-4076	2012	time|abstract[295]	giv|new[295]	_	_
43-2	4077-4078	,	abstract[295]	new[295]	_	_
43-3	4079-4085	Oracle	organization|abstract[295]	new|new[295]	_	_
43-4	4086-4091	award	abstract[295]	new[295]	_	_
43-5	4092-4093	,	_	_	_	_
43-6	4094-4105	Springboard	object|organization[297]	new|new[297]	_	_
43-7	4106-4117	Enterprises	organization[297]	new[297]	_	_
43-8	4118-4119	,	_	_	_	_
43-9	4120-4121	[	_	_	_	_
43-10	4122-4124	17	abstract	new	_	_
43-11	4125-4126	]	_	_	_	_
43-12	4127-4128	[	_	_	_	_
43-13	4129-4131	18	time	giv	_	_
43-14	4132-4133	]	_	_	_	_
43-15	4134-4137	for	_	_	_	_
43-16	4138-4150	professional	abstract[300]	new[300]	_	_
43-17	4151-4165	accomplishment	abstract[300]	new[300]	_	_
43-18	4166-4169	and	_	_	_	_
43-19	4170-4179	mentoring	event[301]	new[301]	_	_
43-20	4180-4182	of	event[301]	new[301]	_	_
43-21	4183-4188	women	event[301]|person[302]	new[301]|new[302]	_	_
43-22	4189-4202	entrepreneurs	event[301]|person[302]	new[301]|new[302]	_	_
43-23	4203-4204	.	_	_	_	_
43-24	4205-4206	[	_	_	_	_
43-25	4207-4208	1	abstract	giv	_	_
43-26	4209-4210	]	_	_	_	_
